TREM2 and cancer: The mezzo-forte subtype matched well with metaplastic cancer cells (subtype I), less hijacked by suppressive cells as in the forte subtype, and exploited alternative tumor-promoting TME niches, exemplified by TREM2+ macrophages and tumor-promoting fibroblasts.